Resalis Therapeutics

Private

TurinHealthcare & Life Scienceshttps://www.resalistherapeutics.com/

Last Round

Strategic

Oct 28, 2024

Total Funding Raised

$21.71M

Company Overview

Resalis Therapeutics is a biotechnology company developing non-coding RNA-based therapies for metabolic disorders such as obesity and fatty liver disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyRNA therapeuticsantisense oligonucleotidemetabolic disordersdrug discoveryobesity treatmentnon-coding RNAMAFLDMASHmetabolic associated fatty liver diseasemetabolic associated steatohepatitisclinical trialsbiotech startupRNA medicineweight loss drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resalis Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Resalis Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Resalis Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Oct 28, 2024
Series A	Jan 4, 2024
Seed	Feb 22, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Alessandro Toniolo

Chief Executive Officer E Amministratore Delegato

Executive Team

Resalis Therapeutics Investors

Notable investors and investment history

Resalis Therapeutics investors
Investor	Rounds
Club degli Investitori	Seed, Series A
Claris Ventures	Series A, Seed
Sunstone Life Science Ventures	Series A
Italian Angels for Growth	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 28, 2024
Sanofi led a strategic funding round.

View all signals

Resalis Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Resalis Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resalis Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersTurin

Employee Range12

Year Founded2021

Last FundingOct 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.